Zydus Biologics’ Ahmedabad injectable facility gets 7 observations in USFDA inspection

Zydus Lifesciences has made headlines as its Zydus Biologics injectable plant in Ahmedabad underwent a USFDA inspection between April 27 and May 5, 2026. The inspection yielded seven observations, but significantly, there were no issues regarding data integrity. Zydus Lifesciences is already in discussions with the USFDA to ensure these observations are addressed in a timely manner.